Literature DB >> 8905499

Underdetection of clinical benign prostatic hyperplasia in a general medical practice.

M F Collins1, R H Friedman, A Ash, R Hall, M A Moskowitz.   

Abstract

OBJECTIVE: To measure detection of clinical benign prostatic hyperplasia (BPH) in a general medicine practice.
DESIGN: Self-administered questionnaire and retrospective ambulatory medical record review.
SETTING: Hospital-based general medicine practice. PATIENTS: Two hundred and four men aged 50 years and older.
MEASUREMENTS AND MAIN RESULTS: Clinical information was obtained from a self-administered questionnaire containing the American Urological Association symptom index and the BPH Impact Index bother scale, and from retrospective review of ambulatory medical records for the previous 24 months. Thirty percent of patients had moderate to severe urinary tract symptoms, and 67% of these individuals were bothered by the symptoms. Only 52% with moderate to severe symptoms recalled any discussion with their primary care physician about their symptoms. There was medical record documentation of a review of urinary tract symptoms in only 18% and a prostate examination in only 64%. Patients with more symptoms and bother tended to recall a discussion of urinary tract symptoms with their physician. However, moderate to severe symptoms and bother were not associated with increased documentation of a history of urinary tract symptoms or prostate examination.
CONCLUSIONS: Clinical BPH was underdetected in a general medicine practice. Because many men do not complain to their physicians about urinary tract symptoms and reduced quality of life, perhaps primary care physicians should pay more attention to recognizing this common condition of older men.

Entities:  

Mesh:

Year:  1996        PMID: 8905499     DOI: 10.1007/bf02599597

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  52 in total

1.  The road to guidelines.

Authors:  J E Wennberg
Journal:  Health Manage Q       Date:  1991

2.  Finding common ground. Guidelines must incorporate new knowledge of outcomes and accommodate values and preferences of individual patients.

Authors:  A G Mulley
Journal:  Health Manage Q       Date:  1991

3.  Some clinical aspects of uroflowmetry in elderly males. A population survey.

Authors:  K M Jensen; J B Jørgensen; P Mogensen; N E Bille-Brahe
Journal:  Scand J Urol Nephrol       Date:  1986

4.  The incidence of benign prostatic obstruction.

Authors:  B Lytton; J M Emery; B M Harvard
Journal:  J Urol       Date:  1968-05       Impact factor: 7.450

Review 5.  Enlightened individual choice vs the public's health: rational prevention from whose perspective?

Authors:  L Goldman
Journal:  J Gen Intern Med       Date:  1995-03       Impact factor: 5.128

6.  High prevalence of benign prostatic hypertrophy in the community.

Authors:  W M Garraway; G N Collins; R J Lee
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

7.  Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia.

Authors:  H A Guess; H M Arrighi; E J Metter; J L Fozard
Journal:  Prostate       Date:  1990       Impact factor: 4.104

8.  Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men.

Authors:  W M Garraway; E B Russell; R J Lee; G N Collins; G B McKelvie; M Hehir; A C Rogers; R J Simpson
Journal:  Br J Gen Pract       Date:  1993-08       Impact factor: 5.386

9.  Consultation patterns in a community survey of men with benign prostatic hyperplasia.

Authors:  R J Simpson; R J Lee; W M Garraway; D King; I McIntosh
Journal:  Br J Gen Pract       Date:  1994-11       Impact factor: 5.386

10.  The internist as gatekeeper. Preparing the general internist for a new role.

Authors:  J M Eisenberg
Journal:  Ann Intern Med       Date:  1985-04       Impact factor: 25.391

View more
  1 in total

1.  Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians.

Authors:  M M Collins; M J Barry; L Bin; R G Roberts; J E Oesterling; F J Fowler
Journal:  J Gen Intern Med       Date:  1997-04       Impact factor: 5.128

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.